Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Market Dynamics: HIV - Combating a Market Slowdown
Datamonitor, Oct 2003, Pages: 136


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

Introduction:
The introduction of structured treatment interruptions and delayed onset to treatment is expected to result in a gradual decline in HIV market growth during the next 5-7 years. As treatment strategies become more complex, physicians will turn towards pharmaceutical companies for drugs with simpler dosing profiles. This In-Depth Commercial Analysis provides a thorough review of current drug use, Swot analyses of marketed products, and a discussion of the life cycle of a typical HIV therapeutic.

Scope:
* Global sales data for all currently marketed drugs, with estimates for 2002 revenue

* Forecasts of drug sales for all currently marketed drugs through to 2010

* Swot analyses for all currently marketed drugs

* Analysis of life cycle management of HIV drugs

* Discussion of the impact of generic competition on the HIV market, through comparisons with the oncology market

Report Highlights:
Market impacts, such as the introduction of structured treatment interruptions (STIs) and delayed onset to treatment, will cause a gradual decline in HIV market growth during the next 5-7 years

Datamonitor believes that revenues of branded products within the developed world will not be significantly affected by generic competition through to 2010

Reasons to Purchase:
* Identify which antiretroviral drug classes have the potential to show the greatest market growth to 2010

* Predict the impact of generics on the antiretroviral markets, as the current market leading products lose patent protection

* Understand how the simplification of therapy regimens and the need to reduce drug-associated side effects will drive development of novel products

* Target the patient segments with the greatest unmet needs



Customers who bought this item also bought

Commercial Insight: HIV - Reshaping Treatment Paradigms

The Global HIV/AIDS Market Outlook to 2012

HIV: Future Treatment Directions - A Strategic Analysis of Market Developments and Opportunities

Pipeline Insight: HIV - The Age of Convenience

Forecast Insight: HIV - Cross-class fixed dose combinations drive continued growth

Global HIV Market: An Analysis

The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective

The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran

The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus

The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria

The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds